Provided by Tiger Trade Technology Pte. Ltd.

Larimar Therapeutics, Inc.

3.12
-0.4300-12.11%
Volume:2.73M
Turnover:9.05M
Market Cap:267.04M
PE:-1.60
High:3.56
Open:3.56
Low:3.12
Close:3.55
52wk High:6.91
52wk Low:1.61
Shares:85.59M
Float Shares:45.15M
Volume Ratio:1.47
T/O Rate:6.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9534
EPS(LYR):-1.3159
ROE:-78.24%
ROA:-42.99%
PB:1.92
PE(LYR):-2.37

Loading ...

Aug 06, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 01, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 26, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 26, 2020

Major Issues Report

8-K/A [Amend] - Current report
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 08, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 08, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2020

Major Issues Report

8-K - Current report
Jun 02, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 24, 2020

Major Issues Report

8-K - Current report
Apr 10, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 09, 2020

Major Issues Report

8-K - Current report
Mar 05, 2020

Major Issues Report

8-K - Current report
Mar 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 05, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]